
GC19270
Olmutinib
Also known as N-[3-[2-[4-(4-methylpiperazin-1-yl)anilino]thieno[3,2-d]pyrimidin-4-yl]oxyphenyl]prop-2-enamide
Olmutinib (HM61713; BI-1482694) is an irreversible EGFR tyrosine kinase inhibitor that binds to a cysteine residue near the kinase domain
ChemicalCAS1353550-13-6MW486.59FormulaC26H26N6O2S
- CAS number
- 1353550-13-6
- Molecular weight
- 486.59
- Formula
- C26H26N6O2S
- Solubility
- DMSO : ≥ 44 mg/mL (90·43 mM)
- InChIKey
- FDMQDKQUTRLUBU-UHFFFAOYSA-N
- Catalogue number
- GC19270
- Brand
- GLPBIO
Computed properties PubChem CID 54758501 · XLogP 4.7 · TPSA 111 Ų · H-bond donors 2
- XLogP
- 4.7
- TPSA
- 111 Ų
- H-bond donors
- 2
- H-bond acceptors
- 8
- Rotatable bonds
- 7
- Heavy atoms
- 35
SMILES CN1CCN(CC1)C2=CC=C(C=C2)NC3=NC4=C(C(=N3)OC5=CC=CC(=C5)NC(=O)C=C)SC=C4
Computed descriptors from PubChem (CID 54758501), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il